MN Advances is sister journal to Molecular Neurodegeneration, a journal that encompasses all aspects of neurodegeneration research at the molecular and cellular levels.
MN Advances is now open for submissions
We proudly announce the launch of Molecular Neurodegeneration Advances (MN Advances), a sister journal to our established Molecular Neurodegeneration. Led by Molecular Neurodegeneration’s own Editor-in-Chief, Dr. Guojun Bu, the MN Advances extensive scope aims to facilitate scientific communication, enabling the translation of fundamental discoveries into improved patient care. We aim to publish impactful research that delves into the molecular pathways driving neurodegeneration, disrupted cellular processes, and pathological changes.
We warmly welcome both established investigators and emerging researchers to submit their work to MN Advances!
Sister journal
Aims and scope
Molecular Neurodegeneration Advances is an open-access, peer-reviewed journal dedicated to advancing research on neurodegeneration at the molecular, cellular, and systems levels. Our journal focuses on the intricate mechanisms underlying neurodegenerative diseases to inform advanced diagnosis and innovative therapies. These may include clinically and pathologically diagnosed conditions such as Alzheimer's disease and related dementias, Parkinson disease and movement disorders, vascular dementia; pathologically defined conditions such as tauopathies, synucleinopathies, TDP-43 proteinopathies, and other neurodegenerative disorders characterized by protein/peptide aggregation; and acute neurodegenerative conditions such as stroke, traumatic brain injury, and spinal cord injury.
Neurodegenerative diseases pose significant challenges to public health, especially as aging population continues to grow globally. Molecular Neurodegeneration Advances seeks to publish cutting-edge research exploring the molecular pathway, cellular process, pathology, biomarker, state-of-the-art technology, diagnosis, drug discovery, and other advancements that may facilitate the development of more effective treatments and potential cures for these disorders.